Breast lumps differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 34: Line 34:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Fibroadenoma]]<ref name="PintoAguiar2014">{{cite journal|last1=Pinto|first1=Joana|last2=Aguiar|first2=Ana Teresa|last3=Duarte|first3=Hálio|last4=Vilaverde|first4=Filipa|last5=Rodrigues|first5=Ângelo|last6=Krug|first6=José Luís|title=Simple and Complex Fibroadenomas|journal=Journal of Ultrasound in Medicine|volume=33|issue=3|year=2014|pages=415–419|issn=02784297|doi=10.7863/ultra.33.3.415}}</ref>
! align="center" style="background:#DCDCDC;" |[[Fibroadenoma]]<ref name="PintoAguiar2014">{{cite journal|last1=Pinto|first1=Joana|last2=Aguiar|first2=Ana Teresa|last3=Duarte|first3=Hálio|last4=Vilaverde|first4=Filipa|last5=Rodrigues|first5=Ângelo|last6=Krug|first6=José Luís|title=Simple and Complex Fibroadenomas|journal=Journal of Ultrasound in Medicine|volume=33|issue=3|year=2014|pages=415–419|issn=02784297|doi=10.7863/ultra.33.3.415}}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* Unknown
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Very slight increased risk of [[breast cancer]] in complex [[fibroadenoma]]
* Very slight increased risk of [[breast cancer]] in complex [[fibroadenoma]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Most common [[benign]] [[tumor]], women aged 20-30 years
* Most common [[benign]] [[tumor]], women aged 20-30 years
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Increased in size during [[pregnancy]] or with [[estrogen]] therapy, and regress after [[menopause]]
* Increased in size during [[pregnancy]] or with [[estrogen]] therapy, and regress after [[menopause]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 54: Line 54:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Proliferative breast lesion without [[atypia]]
* Proliferative breast lesion without [[atypia]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Well-defined
* Well-defined
* Solid mass
* Solid mass
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Mammography]] [[Ultrasound]]   
* [[Mammography]] [[Ultrasound]]   
* [[Biopsy]]
* [[Biopsy]]
Line 65: Line 65:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Breast]] [[cyst]]<ref name="pmid16900392">{{cite journal| author=Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V et al.| title=Benign breast diseases. | journal=J Mammary Gland Biol Neoplasia | year= 2005 | volume= 10 | issue= 4 | pages= 325-35 | pmid=16900392 | doi=10.1007/s10911-006-9006-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16900392  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Breast]] [[cyst]]<ref name="pmid16900392">{{cite journal| author=Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V et al.| title=Benign breast diseases. | journal=J Mammary Gland Biol Neoplasia | year= 2005 | volume= 10 | issue= 4 | pages= 325-35 | pmid=16900392 | doi=10.1007/s10911-006-9006-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16900392  }}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Hormonal]] fluctuation
* [[Hormonal]] fluctuation
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* No increased risk of [[malignancy]] for simple [[cyst]]
* No increased risk of [[malignancy]] for simple [[cyst]]
* <1% for complicated [[cyst]]
* <1% for complicated [[cyst]]
* <1% to 23% for complex [[cyst]]
* <1% to 23% for complex [[cyst]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Common masses found in [[premenopausal]], [[perimenopausal]], and [[postmenopausal]] women
* Common masses found in [[premenopausal]], [[perimenopausal]], and [[postmenopausal]] women
* Mostly seen among [[HRT]] users
* Mostly seen among [[HRT]] users
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* May resolve after aspiration
* May resolve after aspiration
* Further evaluation for not completely resolved masses
* Further evaluation for not completely resolved masses
Line 81: Line 81:
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Solitary
* Solitary
* Cluster of small masses or an ill-defined mass
* Cluster of small masses or an ill-defined mass
Line 89: Line 89:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Nonproliferative breast lesions
* Nonproliferative breast lesions
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* simple [[cyst]]: Well circumscribed, posterior acoustic enhancement without internal echoes  
* simple [[cyst]]: Well circumscribed, posterior acoustic enhancement without internal echoes  
* Complicated [[cyst]]: Homogenous low-level internal echoes due to without solid components
* Complicated [[cyst]]: Homogenous low-level internal echoes due to without solid components
* Complex [[cyst]]: Thick walls greater than 0.5 mm with solid component
* Complex [[cyst]]: Thick walls greater than 0.5 mm with solid component
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
* [[Fine needle aspiration]] ([[FNA]])  
* [[Fine needle aspiration]] ([[FNA]])  
Line 101: Line 101:
|-
|-
! align="center" style="background:#DCDCDC;" |Fibrocystic change<ref name="pmid10693180">{{cite journal| author=Templeman C, Hertweck SP| title=Breast disorders in the pediatric and adolescent patient. | journal=Obstet Gynecol Clin North Am | year= 2000 | volume= 27 | issue= 1 | pages= 19-34 | pmid=10693180 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10693180  }}</ref>
! align="center" style="background:#DCDCDC;" |Fibrocystic change<ref name="pmid10693180">{{cite journal| author=Templeman C, Hertweck SP| title=Breast disorders in the pediatric and adolescent patient. | journal=Obstet Gynecol Clin North Am | year= 2000 | volume= 27 | issue= 1 | pages= 19-34 | pmid=10693180 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10693180  }}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* Unknown
* Imbalance between [[estrogen]] and [[progesterone]]
* Imbalance between [[estrogen]] and [[progesterone]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" left" style="background:#F5F5F5;" |
* No increased risk of [[malignancy]]
* No increased risk of [[malignancy]]
* Slightly increased risk of [[malignancy]] in presence of positive [[familial history]] of [[breast cancer]]
* Slightly increased risk of [[malignancy]] in presence of positive [[familial history]] of [[breast cancer]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown prevalence among adolescents
* Unknown prevalence among adolescents
* >50% in women of reproductive age
* >50% in women of reproductive age
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Become present before menses and improve during mensturation
* Become present before menses and improve during mensturation
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Painful breast tissue
* Painful breast tissue
* Tender, [[nodular]] swelling
* Tender, [[nodular]] swelling
Line 124: Line 124:
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nonproliferative breast lesions
| align="center" style="background:#F5F5F5;" |Nonproliferative breast lesions
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Small [[cysts]] in [[mammary]] zone
* Small [[cysts]] in [[mammary]] zone
* Fibroglandular tissue around the mass
* Fibroglandular tissue around the mass
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]] (it is not recommended for adolescents)
* [[Mammography]] (it is not recommended for adolescents)
Line 133: Line 133:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Galactocele]]<ref name="pmid18180221">{{cite journal| author=Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P et al.| title=Radiologic evaluation of breast disorders related to pregnancy and lactation. | journal=Radiographics | year= 2007 | volume= 27 Suppl 1 | issue=  | pages= S101-24 | pmid=18180221 | doi=10.1148/rg.27si075505 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18180221  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Galactocele]]<ref name="pmid18180221">{{cite journal| author=Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P et al.| title=Radiologic evaluation of breast disorders related to pregnancy and lactation. | journal=Radiographics | year= 2007 | volume= 27 Suppl 1 | issue=  | pages= S101-24 | pmid=18180221 | doi=10.1148/rg.27si075505 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18180221  }}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Milk duct [[obstruction]]
* Milk duct [[obstruction]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* No increased risk of [[malignancy]]
* No increased risk of [[malignancy]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Milk retention [[cysts]] with fluid collection among [[pregnant]] women and during [[breast-feeding]]
* Milk retention [[cysts]] with fluid collection among [[pregnant]] women and during [[breast-feeding]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* After ending [[lactation]], the [[cysts]] resolve
* After ending [[lactation]], the [[cysts]] resolve
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Soft masses
* Soft masses
* [[Cystic]] masses
* [[Cystic]] masses
Line 152: Line 152:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Retention [[cyst]] resulting from lactiferous duct occlusion
* Retention [[cyst]] resulting from lactiferous duct occlusion
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Mammography]]: Intermediate mass in absence of classic fat-fluid level
* [[Mammography]]: Intermediate mass in absence of classic fat-fluid level
* [[Ultrasound]]: Complex mass
* [[Ultrasound]]: Complex mass
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]]
* [[Mammography]]
Line 167: Line 167:
| align="center" style="background:#F5F5F5;" |No increased risk of [[malignancy]]
| align="center" style="background:#F5F5F5;" |No increased risk of [[malignancy]]
| align="center" style="background:#F5F5F5;" |Most common in age of 10-20 years old   
| align="center" style="background:#F5F5F5;" |Most common in age of 10-20 years old   
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* More than 80% resolve spontaneously
* More than 80% resolve spontaneously
* Drainage is essential in rare cases
* Drainage is essential in rare cases
Line 173: Line 173:
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Asymptomatic subareolar mass
* Asymptomatic subareolar mass
* Drainage of clear to brownish fluid
* Drainage of clear to brownish fluid
Line 186: Line 186:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Hemangioma|Hamartoma]]<ref name="pmid12461066">{{cite journal| author=Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC et al.| title=Hamartoma of the breast: a clinicopathological review. | journal=J Clin Pathol | year= 2002 | volume= 55 | issue= 12 | pages= 951-4 | pmid=12461066 | doi= | pmc=1769817 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12461066  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Hemangioma|Hamartoma]]<ref name="pmid12461066">{{cite journal| author=Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC et al.| title=Hamartoma of the breast: a clinicopathological review. | journal=J Clin Pathol | year= 2002 | volume= 55 | issue= 12 | pages= 951-4 | pmid=12461066 | doi= | pmc=1769817 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12461066  }}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* Unknown
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |Coexisting [[malignancy]] can occur
| align="center" style="background:#F5F5F5;" |Coexisting [[malignancy]] can occur
| align="center" style="background:#F5F5F5;" |Common in women older than 35 years old
| align="center" style="background:#F5F5F5;" |Common in women older than 35 years old
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Asymptomatic]] ones found incidentally or painless [[breast lump]]
* [[Asymptomatic]] ones found incidentally or painless [[breast lump]]
* Usually excised
* Usually excised
Line 197: Line 197:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Soft [[breast lump]]
* Soft [[breast lump]]
* Breast enlargement without palpable mass
* Breast enlargement without palpable mass
Line 204: Line 204:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]] proliferation of [[fibrous]], [[glandular]], and fatty tissue
* [[Benign]] proliferation of [[fibrous]], [[glandular]], and fatty tissue
* Thin capsule of [[connective tissue]]
* Thin capsule of [[connective tissue]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Well-described  
* Well-described  
* Discrete, solid, and encapsulated lesion
* Discrete, solid, and encapsulated lesion
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]]
* [[Mammography]]
Line 216: Line 216:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Breast abscess]]<ref name="pmid17639835">{{cite journal| author=Dixon JM| title=Breast abscess. | journal=Br J Hosp Med (Lond) | year= 2007 | volume= 68 | issue= 6 | pages= 315-20 | pmid=17639835 | doi=10.12968/hmed.2007.68.6.23574 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17639835  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Breast abscess]]<ref name="pmid17639835">{{cite journal| author=Dixon JM| title=Breast abscess. | journal=Br J Hosp Med (Lond) | year= 2007 | volume= 68 | issue= 6 | pages= 315-20 | pmid=17639835 | doi=10.12968/hmed.2007.68.6.23574 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17639835  }}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Complication]] of [[breast]] [[mastitis]]
* [[Complication]] of [[breast]] [[mastitis]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* No increased risk of [[malignancy]]
* No increased risk of [[malignancy]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Complication of lactational [[mastitis]] in 14% of cases
* Complication of lactational [[mastitis]] in 14% of cases
* Common among African American women, heavy smokers , and [[obese]] patients
* Common among African American women, heavy smokers , and [[obese]] patients
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Resolve after drainage/
* Resolve after drainage/
* anti-biotic therapy
* anti-biotic therapy
Line 230: Line 230:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Localized [[inflammation]] of [[breast]]
* Localized [[inflammation]] of [[breast]]
* [[Tenderness]]
* [[Tenderness]]
Line 236: Line 236:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Fever]]
* [[Fever]]
* [[Malaise]]
* [[Malaise]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Blood culture]] is required in severe [[infection]]
* [[Blood culture]] is required in severe [[infection]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Inflammatory]] mass  [[Purulent]] material drainage either spontaneously or on [[incision]]
* [[Inflammatory]] mass  [[Purulent]] material drainage either spontaneously or on [[incision]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Fluid collection
* Fluid collection


| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Mastitis]]<ref name="pmid8696751">{{cite journal| author=Dixon JM, Ravisekar O, Chetty U, Anderson TJ| title=Periductal mastitis and duct ectasia: different conditions with different aetiologies. | journal=Br J Surg | year= 1996 | volume= 83 | issue= 6 | pages= 820-2 | pmid=8696751 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8696751  }}</ref><ref name="pmid17267864">{{cite journal| author=Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists| title=ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects. | journal=Obstet Gynecol | year= 2007 | volume= 109 | issue= 2 Pt 1 | pages= 479-80 | pmid=17267864 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17267864  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Mastitis]]<ref name="pmid8696751">{{cite journal| author=Dixon JM, Ravisekar O, Chetty U, Anderson TJ| title=Periductal mastitis and duct ectasia: different conditions with different aetiologies. | journal=Br J Surg | year= 1996 | volume= 83 | issue= 6 | pages= 820-2 | pmid=8696751 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8696751  }}</ref><ref name="pmid17267864">{{cite journal| author=Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists| title=ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects. | journal=Obstet Gynecol | year= 2007 | volume= 109 | issue= 2 Pt 1 | pages= 479-80 | pmid=17267864 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17267864  }}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Inflammation]]
* [[Inflammation]]
* [[Infection]]
* [[Infection]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* No increased risk of [[malignancy]]
* No increased risk of [[malignancy]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Common among lactating women (first three months of [[breast-feeding]])
* Common among lactating women (first three months of [[breast-feeding]])
* Periductal [[mastitis]] among smokers and associated with [[squamous]] [[metaplasia]]
* Periductal [[mastitis]] among smokers and associated with [[squamous]] [[metaplasia]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Resolve after anti-biotic therapy/
* Resolve after anti-biotic therapy/
drainage
drainage
Line 266: Line 266:
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Breast [[tenderness]]
* Breast [[tenderness]]
* Swollen [[breast]] [[tissue]]
* Swollen [[breast]] [[tissue]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Fever]]
* [[Fever]]
* [[Nipple]] [[retraction]]
* [[Nipple]] [[retraction]]
| align="center" style="background:#F5F5F5;" |[[Leukocytosis]]
| align="center" style="background:#F5F5F5;" |[[Leukocytosis]]
| align="center" style="background:#F5F5F5;" |[[Breast]] [[parenchyma]] [[inflammation]]:
| align="left" style="background:#F5F5F5;" |[[Breast]] [[parenchyma]] [[inflammation]]:
* [[Acute]] [[mastitis]]: [[Staphylococcus]] [[infection]]  
* [[Acute]] [[mastitis]]: [[Staphylococcus]] [[infection]]  
* [[Granulomatous]] [[mastitis]]: [[Tuberculosis]] or [[sarcoidosis]] [[infection]]  
* [[Granulomatous]] [[mastitis]]: [[Tuberculosis]] or [[sarcoidosis]] [[infection]]  
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Ill-defined area with hyperechogenicity with inflamed fat lobules
* Ill-defined area with hyperechogenicity with inflamed fat lobules
* Skin thickening
* Skin thickening
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
Line 305: Line 305:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Breast carcinoma]]<ref name="pmid29313949">{{cite journal |vauthors=Siegel RL, Miller KD, Jemal A |title=Cancer statistics, 2018 |journal=CA Cancer J Clin |volume=68 |issue=1 |pages=7–30 |date=January 2018 |pmid=29313949 |doi=10.3322/caac.21442 |url=}}</ref><ref name="pmid16175185">{{cite journal |vauthors=Li CI, Uribe DJ, Daling JR |title=Clinical characteristics of different histologic types of breast cancer |journal=Br. J. Cancer |volume=93 |issue=9 |pages=1046–52 |date=October 2005 |pmid=16175185 |pmc=2361680 |doi=10.1038/sj.bjc.6602787 |url=}}</ref><ref name="pmid19764994">{{cite journal |vauthors=Parise CA, Bauer KR, Brown MM, Caggiano V |title=Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004 |journal=Breast J |volume=15 |issue=6 |pages=593–602 |date=2009 |pmid=19764994 |doi=10.1111/j.1524-4741.2009.00822.x |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Breast carcinoma]]<ref name="pmid29313949">{{cite journal |vauthors=Siegel RL, Miller KD, Jemal A |title=Cancer statistics, 2018 |journal=CA Cancer J Clin |volume=68 |issue=1 |pages=7–30 |date=January 2018 |pmid=29313949 |doi=10.3322/caac.21442 |url=}}</ref><ref name="pmid16175185">{{cite journal |vauthors=Li CI, Uribe DJ, Daling JR |title=Clinical characteristics of different histologic types of breast cancer |journal=Br. J. Cancer |volume=93 |issue=9 |pages=1046–52 |date=October 2005 |pmid=16175185 |pmc=2361680 |doi=10.1038/sj.bjc.6602787 |url=}}</ref><ref name="pmid19764994">{{cite journal |vauthors=Parise CA, Bauer KR, Brown MM, Caggiano V |title=Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004 |journal=Breast J |volume=15 |issue=6 |pages=593–602 |date=2009 |pmid=19764994 |doi=10.1111/j.1524-4741.2009.00822.x |url=}}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Generally unknown
* Generally unknown
* [[Genetic]] factors
* [[Genetic]] factors
Line 311: Line 311:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Most common diagnosed [[cancer]] among women
* Most common diagnosed [[cancer]] among women
* Leading cause of cancer death in women 40-49 years old
* Leading cause of cancer death in women 40-49 years old


| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Positive [[family history]]
* Positive [[family history]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Hard  
* Hard  
* Immobile
* Immobile
Line 327: Line 327:
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Breast size changes
* Breast size changes
* [[Nipple]] abnormality
* [[Nipple]] abnormality
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Molecular alteration in [[epithelial cells]]
* Molecular alteration in [[epithelial cells]]
* Ductal
* Ductal
Line 340: Line 340:
* [[Medullary]]
* [[Medullary]]
* [[Papillary]]
* [[Papillary]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Mammography]]: Spiculated  soft tissue, mass [[microcalcification]]
* [[Mammography]]: Spiculated  soft tissue, mass [[microcalcification]]
* [[Ultrasound]]: Spiculated, hypoechoic lesion, shadowing, internal [[calcification]]
* [[Ultrasound]]: Spiculated, hypoechoic lesion, shadowing, internal [[calcification]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]]
* [[Mammography]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[HER2]] positive or negative
* [[HER2]] positive or negative
* [[Estrogen]] [[receptor]] ([[ER]])
* [[Estrogen]] [[receptor]] ([[ER]])
Line 352: Line 352:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Ductal carcinoma in situ]] ([[DCIS]])<ref name="pmid20071685">{{cite journal |vauthors=Virnig BA, Tuttle TM, Shamliyan T, Kane RL |title=Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes |journal=J. Natl. Cancer Inst. |volume=102 |issue=3 |pages=170–8 |date=February 2010 |pmid=20071685 |doi=10.1093/jnci/djp482 |url=}}</ref><ref name="pmid19001605">{{cite journal |vauthors=Brinton LA, Sherman ME, Carreon JD, Anderson WF |title=Recent trends in breast cancer among younger women in the United States |journal=J. Natl. Cancer Inst. |volume=100 |issue=22 |pages=1643–8 |date=November 2008 |pmid=19001605 |pmc=2720764 |doi=10.1093/jnci/djn344 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Ductal carcinoma in situ]] ([[DCIS]])<ref name="pmid20071685">{{cite journal |vauthors=Virnig BA, Tuttle TM, Shamliyan T, Kane RL |title=Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes |journal=J. Natl. Cancer Inst. |volume=102 |issue=3 |pages=170–8 |date=February 2010 |pmid=20071685 |doi=10.1093/jnci/djp482 |url=}}</ref><ref name="pmid19001605">{{cite journal |vauthors=Brinton LA, Sherman ME, Carreon JD, Anderson WF |title=Recent trends in breast cancer among younger women in the United States |journal=J. Natl. Cancer Inst. |volume=100 |issue=22 |pages=1643–8 |date=November 2008 |pmid=19001605 |pmc=2720764 |doi=10.1093/jnci/djn344 |url=}}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* Unknown
* May be related to genes [[BRCA1]], [[BRCA2]]
* May be related to genes [[BRCA1]], [[BRCA2]]
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Contain 25% of all [[Breast Cancer|breast cancers]]
* Contain 25% of all [[Breast Cancer|breast cancers]]
* Increase risk with aging
* Increase risk with aging
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Positive [[family history]]
* Positive [[family history]]
* nulliparity
* nulliparity
Line 367: Line 367:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* May have normal physical exam
* May have normal physical exam


Line 374: Line 374:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Noninvasive [[breast cancer]]
* Noninvasive [[breast cancer]]
* Heterogenous group of [[neoplastic]] lesions
* Heterogenous group of [[neoplastic]] lesions
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Suspicious [[microcalcification]]
* Suspicious [[microcalcification]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Mammography]]
* [[Mammography]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |Microinvasive [[breast cancer]]<ref name="pmid23791403">{{cite journal |vauthors=Sue GR, Lannin DR, Killelea B, Chagpar AB |title=Predictors of microinvasion and its prognostic role in ductal carcinoma in situ |journal=Am. J. Surg. |volume=206 |issue=4 |pages=478–81 |date=October 2013 |pmid=23791403 |doi=10.1016/j.amjsurg.2013.01.039 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |Microinvasive [[breast cancer]]<ref name="pmid23791403">{{cite journal |vauthors=Sue GR, Lannin DR, Killelea B, Chagpar AB |title=Predictors of microinvasion and its prognostic role in ductal carcinoma in situ |journal=Am. J. Surg. |volume=206 |issue=4 |pages=478–81 |date=October 2013 |pmid=23791403 |doi=10.1016/j.amjsurg.2013.01.039 |url=}}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* Unknown
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Uncommon
* Uncommon
* Commonly referred to [[DCIS]] with microinvasion  
* Commonly referred to [[DCIS]] with microinvasion  
* Average age 50-60 years old
* Average age 50-60 years old
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Nulliparity
* Nulliparity
* Positive [[family history]]
* Positive [[family history]]
Line 399: Line 399:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Solitary  
* Solitary  
* Firm palpable mass
* Firm palpable mass
Line 406: Line 406:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Associated with high grade [[DCIS]]
* Associated with high grade [[DCIS]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* A mass with or without [[calcification]]
* A mass with or without [[calcification]]
* [[stromal]] reaction
* [[stromal]] reaction
Line 415: Line 415:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Breast]] [[sarcoma]]<ref name="pmid22451578">{{cite journal |vauthors=Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT |title=Imaging features of primary breast sarcoma |journal=AJR Am J Roentgenol |volume=198 |issue=4 |pages=W386–93 |date=April 2012 |pmid=22451578 |doi=10.2214/AJR.11.7341 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Breast]] [[sarcoma]]<ref name="pmid22451578">{{cite journal |vauthors=Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT |title=Imaging features of primary breast sarcoma |journal=AJR Am J Roentgenol |volume=198 |issue=4 |pages=W386–93 |date=April 2012 |pmid=22451578 |doi=10.2214/AJR.11.7341 |url=}}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Primary: Unknown
* Primary: Unknown
* Secondary: [[Radiotherapy]]
* Secondary: [[Radiotherapy]]
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Rare type, < 1% of all breast malignancies
* Rare type, < 1% of all breast malignancies
* Average age of between 45-50 years
* Average age of between 45-50 years
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Positive history of [[breast cancer]]
* Positive history of [[breast cancer]]
* Rapid increase in size
* Rapid increase in size
Line 429: Line 429:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Well-defined
* Well-defined
* Firm mass
* Firm mass
Line 437: Line 437:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Heterogeneous nonepithelial malignancies from [[connective tissue]] of breast
* Heterogeneous nonepithelial malignancies from [[connective tissue]] of breast
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Noncalcified oval mass Indistinct margins
* Noncalcified oval mass Indistinct margins
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Mammography]]
* [[Mammography]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Phyllodes tumor]]<ref name="pmid10776873">{{cite journal |vauthors=Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA |title=Phyllodes tumors of the breast: a review of 32 cases |journal=Am Surg |volume=66 |issue=4 |pages=360–6 |date=April 2000 |pmid=10776873 |doi= |url=}}</ref><ref name="pmid11013364">{{cite journal |vauthors=Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK |title=Primary treatment of cystosarcoma phyllodes of the breast |journal=Cancer |volume=89 |issue=7 |pages=1502–11 |date=October 2000 |pmid=11013364 |doi= |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Phyllodes tumor]]<ref name="pmid10776873">{{cite journal |vauthors=Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA |title=Phyllodes tumors of the breast: a review of 32 cases |journal=Am Surg |volume=66 |issue=4 |pages=360–6 |date=April 2000 |pmid=10776873 |doi= |url=}}</ref><ref name="pmid11013364">{{cite journal |vauthors=Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK |title=Primary treatment of cystosarcoma phyllodes of the breast |journal=Cancer |volume=89 |issue=7 |pages=1502–11 |date=October 2000 |pmid=11013364 |doi= |url=}}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* Unknown
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" | ±
| align="center" style="background:#F5F5F5;" | ±
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Most common in [[premenopausal]] women (40-50 years)
* Most common in [[premenopausal]] women (40-50 years)
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Represent 1% of breast tumors
* Represent 1% of breast tumors
* Grow aggressively
* Grow aggressively
Line 460: Line 460:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Smooth and multinodular  
* Smooth and multinodular  
* Well-defined  
* Well-defined  
Line 469: Line 469:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Nonepithelial breast [[neoplasm]] with average size of 5 cm
* Nonepithelial breast [[neoplasm]] with average size of 5 cm
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Solid mass
* Solid mass
* Hypoechoic
* Hypoechoic
* Well-circumscribed
* Well-circumscribed
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]]
* [[Mammography]]
Line 481: Line 481:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Lymphoma]]<ref name="pmid10375092">{{cite journal |vauthors=Brogi E, Harris NL |title=Lymphomas of the breast: pathology and clinical behavior |journal=Semin. Oncol. |volume=26 |issue=3 |pages=357–64 |date=June 1999 |pmid=10375092 |doi= |url=}}</ref><ref name="pmid10859001">{{cite journal |vauthors=Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D |title=Primary breast lymphomas--a retrospective analysis of twelve cases |journal=Acta Oncol |volume=39 |issue=2 |pages=135–9 |date=2000 |pmid=10859001 |doi= |url=}}</ref>  
! align="center" style="background:#DCDCDC;" |[[Lymphoma]]<ref name="pmid10375092">{{cite journal |vauthors=Brogi E, Harris NL |title=Lymphomas of the breast: pathology and clinical behavior |journal=Semin. Oncol. |volume=26 |issue=3 |pages=357–64 |date=June 1999 |pmid=10375092 |doi= |url=}}</ref><ref name="pmid10859001">{{cite journal |vauthors=Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D |title=Primary breast lymphomas--a retrospective analysis of twelve cases |journal=Acta Oncol |volume=39 |issue=2 |pages=135–9 |date=2000 |pmid=10859001 |doi= |url=}}</ref>  
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Non-Hodgkin lymphoma]]
* [[Non-Hodgkin lymphoma]]
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Extremely rare ( 0.04%-0.5%)
* Extremely rare ( 0.04%-0.5%)
* Average age 55-60 years
* Average age 55-60 years
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unilateral mass in older women
* Unilateral mass in older women
* In childbearing women, bilateral and similar to [[inflammatory]] [[breast cancer]], possibly having [[Burkitt lymphoma]]
* In childbearing women, bilateral and similar to [[inflammatory]] [[breast cancer]], possibly having [[Burkitt lymphoma]]
Line 494: Line 494:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Well-defined, firm mass
* Well-defined, firm mass
* Multiple
* Multiple
Line 501: Line 501:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Diffuse [[B cell lymphoma]]
* Diffuse [[B cell lymphoma]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Nonspecific circumscribed masses  
* Nonspecific circumscribed masses  
* Without [[calcification]]
* Without [[calcification]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Mammography]]
* [[Mammography]]
* Core [[biopsy]]
* Core [[biopsy]]
Line 512: Line 512:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Duct ectasia]]<ref name="pmid6286199">{{cite journal |vauthors=Schwartz GF |title=Benign neoplasms and "inflammations" of the breast |journal=Clin Obstet Gynecol |volume=25 |issue=2 |pages=373–85 |date=June 1982 |pmid=6286199 |doi= |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Duct ectasia]]<ref name="pmid6286199">{{cite journal |vauthors=Schwartz GF |title=Benign neoplasms and "inflammations" of the breast |journal=Clin Obstet Gynecol |volume=25 |issue=2 |pages=373–85 |date=June 1982 |pmid=6286199 |doi= |url=}}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* Unknown
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Common among [[perimenopausal]] women
* Common among [[perimenopausal]] women
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Usually resolve spontaneously
* Usually resolve spontaneously


Line 524: Line 524:
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Usually asymptomatic
* Usually asymptomatic
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
Line 530: Line 530:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Distention of subareolar ducts
* Distention of subareolar ducts
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Dilated milk ducts  
* Dilated milk ducts  
* Fluid-filled ducts
* Fluid-filled ducts
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |Intraductal [[papilloma]]<ref name="pmid22878621">{{cite journal |vauthors=Wen X, Cheng W |title=Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors |journal=Ann. Surg. Oncol. |volume=20 |issue=1 |pages=94–101 |date=January 2013 |pmid=22878621 |doi=10.1245/s10434-012-2590-1 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |Intraductal [[papilloma]]<ref name="pmid22878621">{{cite journal |vauthors=Wen X, Cheng W |title=Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors |journal=Ann. Surg. Oncol. |volume=20 |issue=1 |pages=94–101 |date=January 2013 |pmid=22878621 |doi=10.1245/s10434-012-2590-1 |url=}}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* Unknown
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Common in women between 35-55 years old
* Common in women between 35-55 years old
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Possibly benign ones
* Possibly benign ones
* Harbor areas of [[atypia]] or [[DCIS]]
* Harbor areas of [[atypia]] or [[DCIS]]
Line 553: Line 553:
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Solitary or multiple lesion
* Solitary or multiple lesion
* large lump near nipple
* large lump near nipple
Line 560: Line 560:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Growth of papillary cell into a lumen
* Growth of papillary cell into a lumen
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Well-defined
* Well-defined
* Solid nodule
* Solid nodule
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Core needle [[biopsy]]
* Core needle [[biopsy]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Lipoma]]<ref name="pmid16720843">{{cite journal |vauthors=Guray M, Sahin AA |title=Benign breast diseases: classification, diagnosis, and management |journal=Oncologist |volume=11 |issue=5 |pages=435–49 |date=May 2006 |pmid=16720843 |doi=10.1634/theoncologist.11-5-435 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Lipoma]]<ref name="pmid16720843">{{cite journal |vauthors=Guray M, Sahin AA |title=Benign breast diseases: classification, diagnosis, and management |journal=Oncologist |volume=11 |issue=5 |pages=435–49 |date=May 2006 |pmid=16720843 |doi=10.1634/theoncologist.11-5-435 |url=}}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* Unknown
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Common between age of 40-60 years old
* Common between age of 40-60 years old


| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]] tumors
* [[Benign]] tumors
* May experience recurrence
* May experience recurrence
Line 583: Line 583:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Solitary
* Solitary
* Mobile  
* Mobile  
Line 591: Line 591:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Solitary tumor of mature fat cells
* Solitary tumor of mature fat cells
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Well-Circumscribed
* Well-Circumscribed
* Hypoechoic lesion
* Hypoechoic lesion
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Core needle [[biopsy]]
* Core needle [[biopsy]]
* Excisional [[biopsy]]
* Excisional [[biopsy]]
Line 602: Line 602:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Sclerosing adenosis]]<ref name="pmid2804888">{{cite journal| author=Jensen RA, Page DL, Dupont WD, Rogers LW| title=Invasive breast cancer risk in women with sclerosing adenosis. | journal=Cancer | year= 1989 | volume= 64 | issue= 10 | pages= 1977-83 | pmid=2804888 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2804888  }}</ref><ref name="pmid15100339">{{cite journal| author=Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N| title=Lower-category benign breast disease and the risk of invasive breast cancer. | journal=J Natl Cancer Inst | year= 2004 | volume= 96 | issue= 8 | pages= 616-20 | pmid=15100339 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15100339  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Sclerosing adenosis]]<ref name="pmid2804888">{{cite journal| author=Jensen RA, Page DL, Dupont WD, Rogers LW| title=Invasive breast cancer risk in women with sclerosing adenosis. | journal=Cancer | year= 1989 | volume= 64 | issue= 10 | pages= 1977-83 | pmid=2804888 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2804888  }}</ref><ref name="pmid15100339">{{cite journal| author=Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N| title=Lower-category benign breast disease and the risk of invasive breast cancer. | journal=J Natl Cancer Inst | year= 2004 | volume= 96 | issue= 8 | pages= 616-20 | pmid=15100339 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15100339  }}</ref>
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Unknown
* Unknown
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Small risk of [[malignancy]]
* Small risk of [[malignancy]]
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
* Result in repeating pain during mensturation
* Result in repeating pain during mensturation
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* May present as a mass or incidental finding on [[mammogram]]
* May present as a mass or incidental finding on [[mammogram]]
* No treatment is needed
* No treatment is needed
Line 616: Line 616:
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Multiple lesion
* Multiple lesion
* Firm
* Firm
Line 624: Line 624:
! align="center" style="background:#F5F5F5;" |NA
! align="center" style="background:#F5F5F5;" |NA
! align="center" style="background:#F5F5F5;" |Nl
! align="center" style="background:#F5F5F5;" |Nl
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Proliferative disease
* Proliferative disease
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Well-defined or irregular mass
* Well-defined or irregular mass
* [[Microcalcification]]
* [[Microcalcification]]
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* [[Mammography]]
* [[Mammography]]
! align="center" style="background:#F5F5F5;" |NA
! align="center" style="background:#F5F5F5;" |NA
Line 635: Line 635:
|-
|-
! align="center" style="background:#DCDCDC;" |Pseudoangiomatous stromal hyperplasia<ref name="pmid20103437">{{cite journal| author=Celliers L, Wong DD, Bourke A| title=Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features. | journal=Clin Radiol | year= 2010 | volume= 65 | issue= 2 | pages= 145-9 | pmid=20103437 | doi=10.1016/j.crad.2009.10.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20103437  }}</ref><ref name="pmid15454202">{{cite journal| author=Salvador R, Lirola JL, Domínguez R, López M, Risueño N| title=Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients. | journal=Breast | year= 2004 | volume= 13 | issue= 5 | pages= 431-5 | pmid=15454202 | doi=10.1016/j.breast.2003.10.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15454202  }}</ref>
! align="center" style="background:#DCDCDC;" |Pseudoangiomatous stromal hyperplasia<ref name="pmid20103437">{{cite journal| author=Celliers L, Wong DD, Bourke A| title=Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features. | journal=Clin Radiol | year= 2010 | volume= 65 | issue= 2 | pages= 145-9 | pmid=20103437 | doi=10.1016/j.crad.2009.10.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20103437  }}</ref><ref name="pmid15454202">{{cite journal| author=Salvador R, Lirola JL, Domínguez R, López M, Risueño N| title=Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients. | journal=Breast | year= 2004 | volume= 13 | issue= 5 | pages= 431-5 | pmid=15454202 | doi=10.1016/j.breast.2003.10.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15454202  }}</ref>
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Unknown
* Unknown
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Common in reproductive age women
* Common in reproductive age women
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* [[Benign]] stromal [[proliferation]]
* [[Benign]] stromal [[proliferation]]
* Stimulation of vascular lesion
* Stimulation of vascular lesion
Line 647: Line 647:
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Solitary firm mass
* Solitary firm mass
* Thickening
* Thickening
Line 654: Line 654:
! align="center" style="background:#F5F5F5;" |NA
! align="center" style="background:#F5F5F5;" |NA
! align="center" style="background:#F5F5F5;" |Nl
! align="center" style="background:#F5F5F5;" |Nl
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Slit-like spaces between [[glandular]] units   
* Slit-like spaces between [[glandular]] units   
* Confused with mammary [[angiosarcoma]]
* Confused with mammary [[angiosarcoma]]
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Well-defined
* Well-defined
* Solid mass
* Solid mass
* Noncalcified
* Noncalcified
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]]
* [[Mammography]]
Line 667: Line 667:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Mondor's disease]]<ref name="pmid11436415">{{cite journal| author=Becker L, McCurdy LI, Taves DH| title=Superficial thrombophlebitis of the breast (Mondor's disease). | journal=Can Assoc Radiol J | year= 2001 | volume= 52 | issue= 3 | pages= 193-5 | pmid=11436415 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11436415  }}</ref><ref name="pmid1562972">{{cite journal| author=Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A| title=Mondor's disease and breast cancer. | journal=Cancer | year= 1992 | volume= 69 | issue= 9 | pages= 2267-70 | pmid=1562972 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1562972  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Mondor's disease]]<ref name="pmid11436415">{{cite journal| author=Becker L, McCurdy LI, Taves DH| title=Superficial thrombophlebitis of the breast (Mondor's disease). | journal=Can Assoc Radiol J | year= 2001 | volume= 52 | issue= 3 | pages= 193-5 | pmid=11436415 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11436415  }}</ref><ref name="pmid1562972">{{cite journal| author=Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A| title=Mondor's disease and breast cancer. | journal=Cancer | year= 1992 | volume= 69 | issue= 9 | pages= 2267-70 | pmid=1562972 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1562972  }}</ref>
! align="center" style="background:#F5F5F5;" |Complication of:
! align="left" style="background:#F5F5F5;" |Complication of:
* [[Surgery]]
* [[Surgery]]
* Core [[biopsy]]
* Core [[biopsy]]
Line 675: Line 675:
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Uncommon [[benign]] disease
* Uncommon [[benign]] disease
* Occur on outer side of [[breast]] or under [[nipple]]  
* Occur on outer side of [[breast]] or under [[nipple]]  
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* [[Benign]] and self-limiting disease
* [[Benign]] and self-limiting disease
* Resolve after 4-6 weeks
* Resolve after 4-6 weeks
Line 684: Line 684:
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Thick and tender cord on breast skin
* Thick and tender cord on breast skin
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |+
Line 691: Line 691:
! align="center" style="background:#F5F5F5;" |Nl
! align="center" style="background:#F5F5F5;" |Nl
! align="center" style="background:#F5F5F5;" |[[Thrombophlebitis]] of [[superficial]] [[veins]] of the breast
! align="center" style="background:#F5F5F5;" |[[Thrombophlebitis]] of [[superficial]] [[veins]] of the breast
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* [[Tubular]] anechoic structure  
* [[Tubular]] anechoic structure  
* Multiple narrowing areas
* Multiple narrowing areas
! align="center" style="background:#F5F5F5;" |
! align="left" style="background:#F5F5F5;" |
* Clinical examination
* Clinical examination
* [[Ultrasound]]
* [[Ultrasound]]
Line 720: Line 720:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Diabetic]] mastopathy<ref name="pmid11772912">{{cite journal| author=Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB| title="Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. | journal=Diabetes Care | year= 2002 | volume= 25 | issue= 1 | pages= 121-6 | pmid=11772912 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11772912  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Diabetic]] mastopathy<ref name="pmid11772912">{{cite journal| author=Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB| title="Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. | journal=Diabetes Care | year= 2002 | volume= 25 | issue= 1 | pages= 121-6 | pmid=11772912 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11772912  }}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* Unknown
* [[Autoimmune]] reaction
* [[Autoimmune]] reaction
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Lymphocytic]] [[mastitis]] or mastopathy
* [[Lymphocytic]] [[mastitis]] or mastopathy
* Common among [[premenopausal]] women
* Common among [[premenopausal]] women
* Longstanding [[diabetes mellitus type 1]]
* Longstanding [[diabetes mellitus type 1]]
 
| align="left" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Suspicious breast mass
* Suspicious breast mass
* After [[diagnosis]], excision is not required
* After [[diagnosis]], excision is not required
Line 737: Line 735:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Ill-defined mass
* Ill-defined mass
* Immobile
* Immobile
Line 744: Line 742:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Dense keloid-like [[fibrosis]]  
* Dense keloid-like [[fibrosis]]  
* Periductal, lobular, and perivascular [[lymphocytic]] [[Infiltration (medical)|infiltration]]
* Periductal, lobular, and perivascular [[lymphocytic]] [[Infiltration (medical)|infiltration]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Irregular mass
* Irregular mass
* Hypoechoic
* Hypoechoic
* Dense lesion
* Dense lesion
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
* Core needle [[biopsy]]
* Core needle [[biopsy]]
Line 757: Line 755:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Gynecomastia]]<ref name="pmid23397020">{{cite journal| author=Draghi F, Tarantino CC, Madonia L, Ferrozzi G| title=Ultrasonography of the male breast. | journal=J Ultrasound | year= 2011 | volume= 14 | issue= 3 | pages= 122-9 | pmid=23397020 | doi=10.1016/j.jus.2011.06.004 | pmc=3558246 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23397020  }}</ref><ref name="pmid17881754">{{cite journal| author=Braunstein GD| title=Clinical practice. Gynecomastia. | journal=N Engl J Med | year= 2007 | volume= 357 | issue= 12 | pages= 1229-37 | pmid=17881754 | doi=10.1056/NEJMcp070677 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17881754  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Gynecomastia]]<ref name="pmid23397020">{{cite journal| author=Draghi F, Tarantino CC, Madonia L, Ferrozzi G| title=Ultrasonography of the male breast. | journal=J Ultrasound | year= 2011 | volume= 14 | issue= 3 | pages= 122-9 | pmid=23397020 | doi=10.1016/j.jus.2011.06.004 | pmc=3558246 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23397020  }}</ref><ref name="pmid17881754">{{cite journal| author=Braunstein GD| title=Clinical practice. Gynecomastia. | journal=N Engl J Med | year= 2007 | volume= 357 | issue= 12 | pages= 1229-37 | pmid=17881754 | doi=10.1056/NEJMcp070677 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17881754  }}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Hormonal]] imbalance
* [[Hormonal]] imbalance
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 763: Line 761:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Benign breast tissue swelling among men and boys around [[puberty]]
* Benign breast tissue swelling among men and boys around [[puberty]]
 
| align="left" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Benign]] [[proliferation]] of the male breast [[glandular tissue]]  
* [[Benign]] [[proliferation]] of the male breast [[glandular tissue]]  
* Usually underlying nipple mass
* Usually underlying nipple mass
Line 771: Line 768:
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unilateral or bilateral firm mass
* Unilateral or bilateral firm mass
* Breast swelling
* Breast swelling
Line 779: Line 776:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Glandular]] breast changes
* [[Glandular]] breast changes
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Nodular]] pattern
* [[Nodular]] pattern
* Dendritic pattern
* Dendritic pattern
* Diffuse [[glandular]] pattern
* Diffuse [[glandular]] pattern
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]]<ref name="pmid11587103">{{cite journal| author=Lower EE, Hawkins HH, Baughman RP| title=Breast disease in sarcoidosis. | journal=Sarcoidosis Vasc Diffuse Lung Dis | year= 2001 | volume= 18 | issue= 3 | pages= 301-6 | pmid=11587103 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11587103  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]]<ref name="pmid11587103">{{cite journal| author=Lower EE, Hawkins HH, Baughman RP| title=Breast disease in sarcoidosis. | journal=Sarcoidosis Vasc Diffuse Lung Dis | year= 2001 | volume= 18 | issue= 3 | pages= 301-6 | pmid=11587103 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11587103  }}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Systemic involvement in [[sarcoidosis]]
* Systemic involvement in [[sarcoidosis]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Rare in patients with systemic involvement
* Rare in patients with systemic involvement
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]] palpable mass
* [[Benign]] palpable mass
* May mimic [[malignancy]] feature
* May mimic [[malignancy]] feature
Line 802: Line 799:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Firm mass
* Firm mass
* Hard mass
* Hard mass
Line 809: Line 806:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Idiopathic]] [[systemic]] [[granulomatous]] disorder
* [[Idiopathic]] [[systemic]] [[granulomatous]] disorder
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 815: Line 812:
* Ill-defined,
* Ill-defined,
* Spiculated solid mass
* Spiculated solid mass
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Biopsy]]
* [[Biopsy]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Fat necrosis]]<ref name="pmid9423681">{{cite journal| author=Soo MS, Kornguth PJ, Hertzberg BS| title=Fat necrosis in the breast: sonographic features. | journal=Radiology | year= 1998 | volume= 206 | issue= 1 | pages= 261-9 | pmid=9423681 | doi=10.1148/radiology.206.1.9423681 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9423681  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Fat necrosis]]<ref name="pmid9423681">{{cite journal| author=Soo MS, Kornguth PJ, Hertzberg BS| title=Fat necrosis in the breast: sonographic features. | journal=Radiology | year= 1998 | volume= 206 | issue= 1 | pages= 261-9 | pmid=9423681 | doi=10.1148/radiology.206.1.9423681 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9423681  }}</ref>
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Breast [[trauma]]
* Breast [[trauma]]
* Surgical intervention
* Surgical intervention
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Common among women
* Common among women
* May mimic [[malignancy]] features
* May mimic [[malignancy]] features
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]] [[breast lumps]] develop after [[trauma]]/ [[surgery]]
* [[Benign]] [[breast lumps]] develop after [[trauma]]/ [[surgery]]
* Suspicious lumps required [[biopsy]]
* Suspicious lumps required [[biopsy]]
Line 835: Line 832:
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Hard or smooth mass
* Hard or smooth mass
* Solitary mass
* Solitary mass
Line 843: Line 840:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Collections of liquefied fat
* Collections of liquefied fat
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Collections of liquefied fat
* Collections of liquefied fat
* Oil [[cysts]]
* Oil [[cysts]]
| align="center" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA

Revision as of 17:41, 21 January 2019

Breast lumps Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Breast lumps from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Breast lumps differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Breast lumps differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Breast lumps differential diagnosis

on Breast lumps differential diagnosis

Breast lumps differential diagnosis in the news

Blogs on Breast lumps differential diagnosis

Directions to Hospitals Treating Breast lumps

Risk calculators and risk factors for Breast lumps differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Breast lumps must be differentiated from other diseases such as malignancy, cysts, inflammation and non-inflammatory solid lumps. Breast symptoms such as nipple discharge and mastalgia require assessment as well.

Differentiating Breast lumps from other Diseases

Differential diagnosis of breast lumps include:

Diseases Etiology Benign Malignant Clinical manifestation Paraclinical findings Gold standard diagnosis Associated findings
Demography History Symptoms Signs Lab findings Histopathology Imaging
Mass Mastalgia Nipple discharge Breast exam Skin changes LAP Others
Fibroadenoma[1]
  • Unknown
+ + ±
  • Solitary
  • Well-defined
  • Mobile mass
NA Nl
  • Proliferative breast lesion without atypia
  • Well-defined
  • Solid mass
NA
Breast cyst[2] +
  • May resolve after aspiration
  • Further evaluation for not completely resolved masses
+ ±
  • Solitary
  • Cluster of small masses or an ill-defined mass
  • Smooth, firm, and frequently tender
NA Nl
  • Nonproliferative breast lesions
  • simple cyst: Well circumscribed, posterior acoustic enhancement without internal echoes
  • Complicated cyst: Homogenous low-level internal echoes due to without solid components
  • Complex cyst: Thick walls greater than 0.5 mm with solid component
NA
Fibrocystic change[3] +
  • Unknown prevalence among adolescents
  • >50% in women of reproductive age
  • Become present before menses and improve during mensturation
+ + ±
  • Painful breast tissue
  • Tender, nodular swelling
NA Nl Nonproliferative breast lesions
  • Small cysts in mammary zone
  • Fibroglandular tissue around the mass
NA
Galactocele[4] + + ± ± NA Nl
  • Retention cyst resulting from lactiferous duct occlusion
NA
Cysts of montgomery[5] Obstruction of periareolar glands of montgomery + No increased risk of malignancy Most common in age of 10-20 years old
  • More than 80% resolve spontaneously
  • Drainage is essential in rare cases
+ ± ±
  • Asymptomatic subareolar mass
  • Drainage of clear to brownish fluid
± NA Nl Acute inflammation due to obstruction of the Montgomery's gland Single cystic lesion in retroareolar area Ultrasound NA
Hamartoma[6]
  • Unknown
+ Coexisting malignancy can occur Common in women older than 35 years old ±
  • Soft breast lump
  • Breast enlargement without palpable mass
± NA Nl
  • Well-described
  • Discrete, solid, and encapsulated lesion
NA
Breast abscess[7] +
  • Complication of lactational mastitis in 14% of cases
  • Common among African American women, heavy smokers , and obese patients
  • Resolve after drainage/
  • anti-biotic therapy
+ + +
  • Fluid collection
NA
Mastitis[8][9] +
  • Resolve after anti-biotic therapy/

drainage

± + ± + Leukocytosis Breast parenchyma inflammation:
  • Ill-defined area with hyperechogenicity with inflamed fat lobules
  • Skin thickening
NA
Diseases Etiology Benign Malignant Demography History Mass Pain Nipple discharge Breast exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Breast carcinoma[10][11][12] +
  • Most common diagnosed cancer among women
  • Leading cause of cancer death in women 40-49 years old
+ ±
  • Hard
  • Immobile
  • Solitary
  • Irregular margin
± ±
  • Breast size changes
  • Nipple abnormality
Nl
Ductal carcinoma in situ (DCIS)[13][14] + ± ±
  • May have normal physical exam
NA Nl NA
Microinvasive breast cancer[15]
  • Unknown

+
  • Uncommon
  • Commonly referred to DCIS with microinvasion
  • Average age 50-60 years old
+ ±
  • Solitary
  • Firm palpable mass
± NA Nl
  • Associated with high grade DCIS
Mammography NA
Breast sarcoma[16] +
  • Rare type, < 1% of all breast malignancies
  • Average age of between 45-50 years
+
  • Well-defined
  • Firm mass
± NA Nl
  • Noncalcified oval mass Indistinct margins
NA
Phyllodes tumor[17][18]
  • Unknown
± ± ±
  • Smooth and multinodular
  • Well-defined
  • Firm mass
  • Mobile
NA Nl
  • Nonepithelial breast neoplasm with average size of 5 cm
  • Solid mass
  • Hypoechoic
  • Well-circumscribed
NA
Lymphoma[19][20] +
  • Extremely rare ( 0.04%-0.5%)
  • Average age 55-60 years
+
  • Well-defined, firm mass
  • Multiple
± NA Nl NA
Duct ectasia[21]
  • Unknown
+
  • Usually resolve spontaneously
± ± ±
  • Usually asymptomatic
NA Nl
  • Distention of subareolar ducts
  • Dilated milk ducts
  • Fluid-filled ducts
NA
Intraductal papilloma[22]
  • Unknown
+
  • Common in women between 35-55 years old
+ ± ±
  • Solitary or multiple lesion
  • large lump near nipple
NA Nl
  • Growth of papillary cell into a lumen
  • Well-defined
  • Solid nodule
NA
Lipoma[23]
  • Unknown
+
  • Common between age of 40-60 years old
  • Benign tumors
  • May experience recurrence
+
  • Solitary
  • Mobile
  • Soft mass
NA Nl
  • Solitary tumor of mature fat cells
  • Well-Circumscribed
  • Hypoechoic lesion
NA
Sclerosing adenosis[24][25]
  • Unknown
+
  • Result in repeating pain during mensturation
  • May present as a mass or incidental finding on mammogram
  • No treatment is needed
± +
  • Multiple lesion
  • Firm
  • Tender nodules
± NA Nl
  • Proliferative disease
NA
Pseudoangiomatous stromal hyperplasia[26][27]
  • Unknown
+
  • Common in reproductive age women
+
  • Solitary firm mass
  • Thickening
NA Nl
  • Well-defined
  • Solid mass
  • Noncalcified
NA
Mondor's disease[28][29] Complication of: +
  • Benign and self-limiting disease
  • Resolve after 4-6 weeks
+ +
  • Thick and tender cord on breast skin
+ NA Nl Thrombophlebitis of superficial veins of the breast
  • Tubular anechoic structure
  • Multiple narrowing areas
NA
Diseases Etiology Benign Malignant Demography History Mass Pain Nipple discharge Breast exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Diabetic mastopathy[30] +
  • Suspicious breast mass
  • After diagnosis, excision is not required
+
  • Ill-defined mass
  • Immobile
NA Nl
  • Irregular mass
  • Hypoechoic
  • Dense lesion
NA
Gynecomastia[31][32] +
  • Benign breast tissue swelling among men and boys around puberty
+ ± ±
  • Unilateral or bilateral firm mass
  • Breast swelling
  • Rubbery mass
NA Nl NA
Sarcoidosis[33] +
  • Rare in patients with systemic involvement
+
  • Firm mass
  • Hard mass
NA Nl
  • Irregular,
  • Ill-defined,
  • Spiculated solid mass
NA
Fat necrosis[34]
  • Breast trauma
  • Surgical intervention
+ + ±
  • Hard or smooth mass
  • Solitary mass
  • Mobile
NA Nl
  • Collections of liquefied fat
  • Collections of liquefied fat
  • Oil cysts
NA

References

  1. Pinto, Joana; Aguiar, Ana Teresa; Duarte, Hálio; Vilaverde, Filipa; Rodrigues, Ângelo; Krug, José Luís (2014). "Simple and Complex Fibroadenomas". Journal of Ultrasound in Medicine. 33 (3): 415–419. doi:10.7863/ultra.33.3.415. ISSN 0278-4297.
  2. Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V; et al. (2005). "Benign breast diseases". J Mammary Gland Biol Neoplasia. 10 (4): 325–35. doi:10.1007/s10911-006-9006-4. PMID 16900392.
  3. Templeman C, Hertweck SP (2000). "Breast disorders in the pediatric and adolescent patient". Obstet Gynecol Clin North Am. 27 (1): 19–34. PMID 10693180.
  4. Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P; et al. (2007). "Radiologic evaluation of breast disorders related to pregnancy and lactation". Radiographics. 27 Suppl 1: S101–24. doi:10.1148/rg.27si075505. PMID 18180221.
  5. De Silva NK, Brandt ML (2006). "Disorders of the breast in children and adolescents, Part 2: breast masses". J Pediatr Adolesc Gynecol. 19 (6): 415–8. doi:10.1016/j.jpag.2006.09.002. PMID 17174833.
  6. Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC; et al. (2002). "Hamartoma of the breast: a clinicopathological review". J Clin Pathol. 55 (12): 951–4. PMC 1769817. PMID 12461066.
  7. Dixon JM (2007). "Breast abscess". Br J Hosp Med (Lond). 68 (6): 315–20. doi:10.12968/hmed.2007.68.6.23574. PMID 17639835.
  8. Dixon JM, Ravisekar O, Chetty U, Anderson TJ (1996). "Periductal mastitis and duct ectasia: different conditions with different aetiologies". Br J Surg. 83 (6): 820–2. PMID 8696751.
  9. Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists (2007). "ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects". Obstet Gynecol. 109 (2 Pt 1): 479–80. PMID 17267864.
  10. Siegel RL, Miller KD, Jemal A (January 2018). "Cancer statistics, 2018". CA Cancer J Clin. 68 (1): 7–30. doi:10.3322/caac.21442. PMID 29313949.
  11. Li CI, Uribe DJ, Daling JR (October 2005). "Clinical characteristics of different histologic types of breast cancer". Br. J. Cancer. 93 (9): 1046–52. doi:10.1038/sj.bjc.6602787. PMC 2361680. PMID 16175185.
  12. Parise CA, Bauer KR, Brown MM, Caggiano V (2009). "Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004". Breast J. 15 (6): 593–602. doi:10.1111/j.1524-4741.2009.00822.x. PMID 19764994.
  13. Virnig BA, Tuttle TM, Shamliyan T, Kane RL (February 2010). "Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes". J. Natl. Cancer Inst. 102 (3): 170–8. doi:10.1093/jnci/djp482. PMID 20071685.
  14. Brinton LA, Sherman ME, Carreon JD, Anderson WF (November 2008). "Recent trends in breast cancer among younger women in the United States". J. Natl. Cancer Inst. 100 (22): 1643–8. doi:10.1093/jnci/djn344. PMC 2720764. PMID 19001605.
  15. Sue GR, Lannin DR, Killelea B, Chagpar AB (October 2013). "Predictors of microinvasion and its prognostic role in ductal carcinoma in situ". Am. J. Surg. 206 (4): 478–81. doi:10.1016/j.amjsurg.2013.01.039. PMID 23791403.
  16. Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT (April 2012). "Imaging features of primary breast sarcoma". AJR Am J Roentgenol. 198 (4): W386–93. doi:10.2214/AJR.11.7341. PMID 22451578.
  17. Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA (April 2000). "Phyllodes tumors of the breast: a review of 32 cases". Am Surg. 66 (4): 360–6. PMID 10776873.
  18. Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK (October 2000). "Primary treatment of cystosarcoma phyllodes of the breast". Cancer. 89 (7): 1502–11. PMID 11013364.
  19. Brogi E, Harris NL (June 1999). "Lymphomas of the breast: pathology and clinical behavior". Semin. Oncol. 26 (3): 357–64. PMID 10375092.
  20. Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D (2000). "Primary breast lymphomas--a retrospective analysis of twelve cases". Acta Oncol. 39 (2): 135–9. PMID 10859001.
  21. Schwartz GF (June 1982). "Benign neoplasms and "inflammations" of the breast". Clin Obstet Gynecol. 25 (2): 373–85. PMID 6286199.
  22. Wen X, Cheng W (January 2013). "Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors". Ann. Surg. Oncol. 20 (1): 94–101. doi:10.1245/s10434-012-2590-1. PMID 22878621.
  23. Guray M, Sahin AA (May 2006). "Benign breast diseases: classification, diagnosis, and management". Oncologist. 11 (5): 435–49. doi:10.1634/theoncologist.11-5-435. PMID 16720843.
  24. Jensen RA, Page DL, Dupont WD, Rogers LW (1989). "Invasive breast cancer risk in women with sclerosing adenosis". Cancer. 64 (10): 1977–83. PMID 2804888.
  25. Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N (2004). "Lower-category benign breast disease and the risk of invasive breast cancer". J Natl Cancer Inst. 96 (8): 616–20. PMID 15100339.
  26. Celliers L, Wong DD, Bourke A (2010). "Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features". Clin Radiol. 65 (2): 145–9. doi:10.1016/j.crad.2009.10.003. PMID 20103437.
  27. Salvador R, Lirola JL, Domínguez R, López M, Risueño N (2004). "Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients". Breast. 13 (5): 431–5. doi:10.1016/j.breast.2003.10.011. PMID 15454202.
  28. Becker L, McCurdy LI, Taves DH (2001). "Superficial thrombophlebitis of the breast (Mondor's disease)". Can Assoc Radiol J. 52 (3): 193–5. PMID 11436415.
  29. Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A (1992). "Mondor's disease and breast cancer". Cancer. 69 (9): 2267–70. PMID 1562972.
  30. Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB (2002). ""Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes". Diabetes Care. 25 (1): 121–6. PMID 11772912.
  31. Draghi F, Tarantino CC, Madonia L, Ferrozzi G (2011). "Ultrasonography of the male breast". J Ultrasound. 14 (3): 122–9. doi:10.1016/j.jus.2011.06.004. PMC 3558246. PMID 23397020.
  32. Braunstein GD (2007). "Clinical practice. Gynecomastia". N Engl J Med. 357 (12): 1229–37. doi:10.1056/NEJMcp070677. PMID 17881754.
  33. Lower EE, Hawkins HH, Baughman RP (2001). "Breast disease in sarcoidosis". Sarcoidosis Vasc Diffuse Lung Dis. 18 (3): 301–6. PMID 11587103.
  34. Soo MS, Kornguth PJ, Hertzberg BS (1998). "Fat necrosis in the breast: sonographic features". Radiology. 206 (1): 261–9. doi:10.1148/radiology.206.1.9423681. PMID 9423681.


Template:WikiDoc Sources